COVID-19 Impact on Global Substance Abuse Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: C84951557876EN
QYResearch

Abstracts

This report focuses on the global Substance Abuse Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Substance Abuse Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Indivior
• Pfizer
• Alkermes
• Novartis
• Mylan
• Cipla
• Glenmark
• Dr. Reddy's Laboratories
• Teva Pharmaceutical

Market segment by Type, the product can be split into

• Opioid Addiction
• Tobacco/Nicotine Addiction
• Alcohol Dependence

Market segment by Application, split into

• Hospital & Clinics
• Residential (non-hospital)

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Substance Abuse Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Substance Abuse Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Substance Abuse Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Substance Abuse Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Substance Abuse Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Opioid Addiction
  1.4.3 Tobacco/Nicotine Addiction
  1.4.4 Alcohol Dependence
1.5 Market by Application
  1.5.1 Global Substance Abuse Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital & Clinics
  1.5.3 Residential (non-hospital)
1.6 Coronavirus Disease 2019 (Covid-19): Substance Abuse Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Substance Abuse Therapeutics Industry
    1.6.1.1 Substance Abuse Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Substance Abuse Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Substance Abuse Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Substance Abuse Therapeutics Market Perspective (2015-2026)
2.2 Substance Abuse Therapeutics Growth Trends by Regions
  2.2.1 Substance Abuse Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Substance Abuse Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Substance Abuse Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Substance Abuse Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Substance Abuse Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Substance Abuse Therapeutics Players by Market Size
  3.1.1 Global Top Substance Abuse Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Substance Abuse Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Substance Abuse Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Substance Abuse Therapeutics Market Concentration Ratio
  3.2.1 Global Substance Abuse Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Substance Abuse Therapeutics Revenue in 2019
3.3 Substance Abuse Therapeutics Key Players Head office and Area Served
3.4 Key Players Substance Abuse Therapeutics Product Solution and Service
3.5 Date of Enter into Substance Abuse Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Substance Abuse Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Substance Abuse Therapeutics Forecasted Market Size by Type (2021-2026)

5 SUBSTANCE ABUSE THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Substance Abuse Therapeutics Market Size by Application (2015-2020)
5.2 Global Substance Abuse Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Substance Abuse Therapeutics Market Size (2015-2020)
6.2 Substance Abuse Therapeutics Key Players in North America (2019-2020)
6.3 North America Substance Abuse Therapeutics Market Size by Type (2015-2020)
6.4 North America Substance Abuse Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Substance Abuse Therapeutics Market Size (2015-2020)
7.2 Substance Abuse Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Substance Abuse Therapeutics Market Size by Type (2015-2020)
7.4 Europe Substance Abuse Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Substance Abuse Therapeutics Market Size (2015-2020)
8.2 Substance Abuse Therapeutics Key Players in China (2019-2020)
8.3 China Substance Abuse Therapeutics Market Size by Type (2015-2020)
8.4 China Substance Abuse Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Substance Abuse Therapeutics Market Size (2015-2020)
9.2 Substance Abuse Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Substance Abuse Therapeutics Market Size by Type (2015-2020)
9.4 Japan Substance Abuse Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Substance Abuse Therapeutics Market Size (2015-2020)
10.2 Substance Abuse Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Substance Abuse Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Substance Abuse Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Substance Abuse Therapeutics Market Size (2015-2020)
11.2 Substance Abuse Therapeutics Key Players in India (2019-2020)
11.3 India Substance Abuse Therapeutics Market Size by Type (2015-2020)
11.4 India Substance Abuse Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Substance Abuse Therapeutics Market Size (2015-2020)
12.2 Substance Abuse Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Substance Abuse Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Substance Abuse Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Indivior
  13.1.1 Indivior Company Details
  13.1.2 Indivior Business Overview and Its Total Revenue
  13.1.3 Indivior Substance Abuse Therapeutics Introduction
  13.1.4 Indivior Revenue in Substance Abuse Therapeutics Business (2015-2020))
  13.1.5 Indivior Recent Development
13.2 Pfizer
  13.2.1 Pfizer Company Details
  13.2.2 Pfizer Business Overview and Its Total Revenue
  13.2.3 Pfizer Substance Abuse Therapeutics Introduction
  13.2.4 Pfizer Revenue in Substance Abuse Therapeutics Business (2015-2020)
  13.2.5 Pfizer Recent Development
13.3 Alkermes
  13.3.1 Alkermes Company Details
  13.3.2 Alkermes Business Overview and Its Total Revenue
  13.3.3 Alkermes Substance Abuse Therapeutics Introduction
  13.3.4 Alkermes Revenue in Substance Abuse Therapeutics Business (2015-2020)
  13.3.5 Alkermes Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Substance Abuse Therapeutics Introduction
  13.4.4 Novartis Revenue in Substance Abuse Therapeutics Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 Mylan
  13.5.1 Mylan Company Details
  13.5.2 Mylan Business Overview and Its Total Revenue
  13.5.3 Mylan Substance Abuse Therapeutics Introduction
  13.5.4 Mylan Revenue in Substance Abuse Therapeutics Business (2015-2020)
  13.5.5 Mylan Recent Development
13.6 Cipla
  13.6.1 Cipla Company Details
  13.6.2 Cipla Business Overview and Its Total Revenue
  13.6.3 Cipla Substance Abuse Therapeutics Introduction
  13.6.4 Cipla Revenue in Substance Abuse Therapeutics Business (2015-2020)
  13.6.5 Cipla Recent Development
13.7 Glenmark
  13.7.1 Glenmark Company Details
  13.7.2 Glenmark Business Overview and Its Total Revenue
  13.7.3 Glenmark Substance Abuse Therapeutics Introduction
  13.7.4 Glenmark Revenue in Substance Abuse Therapeutics Business (2015-2020)
  13.7.5 Glenmark Recent Development
13.8 Dr. Reddy's Laboratories
  13.8.1 Dr. Reddy's Laboratories Company Details
  13.8.2 Dr. Reddy's Laboratories Business Overview and Its Total Revenue
  13.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Introduction
  13.8.4 Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2015-2020)
  13.8.5 Dr. Reddy's Laboratories Recent Development
13.9 Teva Pharmaceutical
  13.9.1 Teva Pharmaceutical Company Details
  13.9.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  13.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Introduction
  13.9.4 Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2015-2020)
  13.9.5 Teva Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Substance Abuse Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Substance Abuse Therapeutics Revenue
Table 3. Ranking of Global Top Substance Abuse Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Substance Abuse Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Opioid Addiction
Table 6. Key Players of Tobacco/Nicotine Addiction
Table 7. Key Players of Alcohol Dependence
Table 8. COVID-19 Impact Global Market: (Four Substance Abuse Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Substance Abuse Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Substance Abuse Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Substance Abuse Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Substance Abuse Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Substance Abuse Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Substance Abuse Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Substance Abuse Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Substance Abuse Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Substance Abuse Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Substance Abuse Therapeutics Players
Table 24. Global Substance Abuse Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Substance Abuse Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Substance Abuse Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Substance Abuse Therapeutics as of 2019)
Table 27. Global Substance Abuse Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Substance Abuse Therapeutics Product Solution and Service
Table 30. Date of Enter into Substance Abuse Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Substance Abuse Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Substance Abuse Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Substance Abuse Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Substance Abuse Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Substance Abuse Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Substance Abuse Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Substance Abuse Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Substance Abuse Therapeutics Market Share (2019-2020)
Table 40. North America Substance Abuse Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Substance Abuse Therapeutics Market Share by Type (2015-2020)
Table 42. North America Substance Abuse Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Substance Abuse Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Substance Abuse Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Substance Abuse Therapeutics Market Share (2019-2020)
Table 46. Europe Substance Abuse Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Substance Abuse Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Substance Abuse Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Substance Abuse Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Substance Abuse Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Substance Abuse Therapeutics Market Share (2019-2020)
Table 52. China Substance Abuse Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Substance Abuse Therapeutics Market Share by Type (2015-2020)
Table 54. China Substance Abuse Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Substance Abuse Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Substance Abuse Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Substance Abuse Therapeutics Market Share (2019-2020)
Table 58. Japan Substance Abuse Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Substance Abuse Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Substance Abuse Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Substance Abuse Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Substance Abuse Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Substance Abuse Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Substance Abuse Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Substance Abuse Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Substance Abuse Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Substance Abuse Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Substance Abuse Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Substance Abuse Therapeutics Market Share (2019-2020)
Table 70. India Substance Abuse Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Substance Abuse Therapeutics Market Share by Type (2015-2020)
Table 72. India Substance Abuse Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Substance Abuse Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Substance Abuse Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Substance Abuse Therapeutics Market Share (2019-2020)
Table 76. Central & South America Substance Abuse Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Substance Abuse Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Substance Abuse Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Substance Abuse Therapeutics Market Share by Application (2015-2020)
Table 80. Indivior Company Details
Table 81. Indivior Business Overview
Table 82. Indivior Product
Table 83. Indivior Revenue in Substance Abuse Therapeutics Business (2015-2020) (Million US$)
Table 84. Indivior Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Substance Abuse Therapeutics Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Alkermes Company Details
Table 91. Alkermes Business Overview
Table 92. Alkermes Product
Table 93. Alkermes Revenue in Substance Abuse Therapeutics Business (2015-2020) (Million US$)
Table 94. Alkermes Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Substance Abuse Therapeutics Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Mylan Company Details
Table 101. Mylan Business Overview
Table 102. Mylan Product
Table 103. Mylan Revenue in Substance Abuse Therapeutics Business (2015-2020) (Million US$)
Table 104. Mylan Recent Development
Table 105. Cipla Company Details
Table 106. Cipla Business Overview
Table 107. Cipla Product
Table 108. Cipla Revenue in Substance Abuse Therapeutics Business (2015-2020) (Million US$)
Table 109. Cipla Recent Development
Table 110. Glenmark Company Details
Table 111. Glenmark Business Overview
Table 112. Glenmark Product
Table 113. Glenmark Revenue in Substance Abuse Therapeutics Business (2015-2020) (Million US$)
Table 114. Glenmark Recent Development
Table 115. Dr. Reddy's Laboratories Business Overview
Table 116. Dr. Reddy's Laboratories Product
Table 117. Dr. Reddy's Laboratories Company Details
Table 118. Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2015-2020) (Million US$)
Table 119. Dr. Reddy's Laboratories Recent Development
Table 120. Teva Pharmaceutical Company Details
Table 121. Teva Pharmaceutical Business Overview
Table 122. Teva Pharmaceutical Product
Table 123. Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2015-2020) (Million US$)
Table 124. Teva Pharmaceutical Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Substance Abuse Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Opioid Addiction Features
Figure 3. Tobacco/Nicotine Addiction Features
Figure 4. Alcohol Dependence Features
Figure 5. Global Substance Abuse Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital & Clinics Case Studies
Figure 7. Residential (non-hospital) Case Studies
Figure 8. Substance Abuse Therapeutics Report Years Considered
Figure 9. Global Substance Abuse Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Substance Abuse Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Substance Abuse Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Substance Abuse Therapeutics Market Share by Players in 2019
Figure 14. Global Top Substance Abuse Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Substance Abuse Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Substance Abuse Therapeutics Revenue in 2019
Figure 16. North America Substance Abuse Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Substance Abuse Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Substance Abuse Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Substance Abuse Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Substance Abuse Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Substance Abuse Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Substance Abuse Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Indivior Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Indivior Revenue Growth Rate in Substance Abuse Therapeutics Business (2015-2020)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Substance Abuse Therapeutics Business (2015-2020)
Figure 27. Alkermes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Alkermes Revenue Growth Rate in Substance Abuse Therapeutics Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Substance Abuse Therapeutics Business (2015-2020)
Figure 31. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Mylan Revenue Growth Rate in Substance Abuse Therapeutics Business (2015-2020)
Figure 33. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Cipla Revenue Growth Rate in Substance Abuse Therapeutics Business (2015-2020)
Figure 35. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Glenmark Revenue Growth Rate in Substance Abuse Therapeutics Business (2015-2020)
Figure 37. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Dr. Reddy's Laboratories Revenue Growth Rate in Substance Abuse Therapeutics Business (2015-2020)
Figure 39. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Teva Pharmaceutical Revenue Growth Rate in Substance Abuse Therapeutics Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed